The Chemours Company
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $746.0M | $7.0M | $-90.0M | $400.0M | $423.0M |
| Depreciation & Amortization | $273.0M | $284.0M | $267.0M | $257.0M | $261.0M |
| Depreciation | $269.0M | $281.0M | $264.0M | $254.0M | $255.0M |
| Amortization | — | — | — | — | — |
| Stock-Based Compensation | $29.0M | — | — | — | — |
| Net Cash from Operating Activities | $640.0M | $594.0M | $182.0M | $505.0M | $798.0M |
| Investing Activities | |||||
| Capital Expenditures | $411.0M | $338.0M | $519.0M | $604.0M | $438.0M |
| Business Acquisitions | $0 | $0 | — | — | — |
| Net Cash from Investing Activities | $-370.0M | $357.0M | $-497.0M | $-560.0M | $-424.0M |
| Financing Activities | |||||
| Dividends Paid | $22.0M | $22.0M | $105.0M | $0 | $0 |
| Stock Repurchases | $106.0M | $0 | — | — | — |
| Net Cash from Financing Activities | $352.0M | $-396.0M | $687.0M | $55.0M | $-374.0M |
| Net Change in Cash | $654.0M | $536.0M | $366.0M | $0 | $0 |
| Free Cash Flow | $229.0M | $256.0M | $-337.0M | $-99.0M | $360.0M |